In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CGI Pharmaceuticals Inc.

Division of Gilead Sciences Inc.

Latest From CGI Pharmaceuticals Inc.

Gilead, JAKed About Cancer Research, Buys YM BioScienses

Gilead will buy the Canadian cancer specialist for $510 million, gaining the lead drug CYT387, a JAK1/JAK2 inhibitor that has demonstrated positive results in myelofibrosis patients.

BioPharmaceutical Deals

Flagship aims to keep early-stage innovators afloat with $270m fund

At a time when venture capitalists are avoiding the rough waters of investing in small, early-stage innovators, Flagship Ventures has held steady.

Pharmacyclics clinches $150 million up front from Janssen in blood cancer deal

Pharmacyclics has received $150 million up front under a development and commercialisation deal with Johnson & Johnson unit Janssen Biotech for a first-in-class oral candidate for haematological malignancies currently in Phase II trials.

Cancer Orthopedics

Management promotion at Gilead

Gilead Sciences has named Dr Muzammil Mansuri senior vice-president of R&D strategy and corporate development, a role that expands his current responsibilities as senior VP of R&D strategy to include leadership of corporate development and alliance management. Dr Mansuri joined Gilead in July 2010, following the company's acquisition of CGI Pharmaceuticals.

See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Cellular Genomics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Gilead Sciences Inc.
  • Senior Management
  • Contact Info
  • CGI Pharmaceuticals Inc.
    Phone: (203) 315-1222
    36 East Industrial Rd.
    Branford, CT 06405